TAS2R40
geneOn this page
Summary
TAS2R40 (taste 2 receptor member 40, HGNC:18885) is a protein-coding gene on chromosome 7q34, encoding Taste receptor type 2 member 40 (P59535). Gustducin-coupled receptor implicated in the perception of bitter compounds in the oral cavity and the gastrointestinal tract.
This gene encodes a member of the bitter taste receptor family which belong to the G protein-coupled receptor superfamily and are predominantly expressed in taste receptor cells of the tongue and palate epithelia. This intronless taste receptor gene encodes a seven-transmembrane receptor protein, functioning as a bitter taste receptor. This gene is clustered together with eight other taste receptor genes on chromosome 7. A decrease in the expression of this gene is associated with hypogeusia.
Source: NCBI Gene 259286 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 43 total
- Druggable target: yes — 1 molecules with ChEMBL bioactivity
- MANE Select transcript:
NM_176882
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18885 |
| Approved symbol | TAS2R40 |
| Name | taste 2 receptor member 40 |
| Location | 7q34 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000221937 |
| Ensembl biotype | protein_coding |
| OMIM | 613964 |
| Entrez | 259286 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000408947
RefSeq mRNA: 1 — MANE Select: NM_176882
NM_176882
CCDS: CCDS43662
Canonical transcript exons
ENST00000408947 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001569176 | 143222037 | 143223079 |
Expression profiles
Bgee: expression breadth broad, 35 present calls, max score 61.35.
Top tissues by expression
220 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| corpus callosum | UBERON:0002336 | 61.35 | gold quality |
| blood | UBERON:0000178 | 58.70 | gold quality |
| leukocyte | CL:0000738 | 52.76 | gold quality |
| monocyte | CL:0000576 | 52.75 | gold quality |
| sural nerve | UBERON:0015488 | 49.26 | silver quality |
| spleen | UBERON:0002106 | 49.18 | gold quality |
| vermiform appendix | UBERON:0001154 | 46.08 | gold quality |
| caecum | UBERON:0001153 | 44.64 | gold quality |
| right lung | UBERON:0002167 | 44.62 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| vastus lateralis | UBERON:0001379 | 41.41 | gold quality |
| quadriceps femoris | UBERON:0001377 | 41.37 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| medial globus pallidus | UBERON:0002477 | 41.27 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| bone marrow cell | CL:0002092 | 40.86 | gold quality |
| globus pallidus | UBERON:0001875 | 40.82 | gold quality |
| amniotic fluid | UBERON:0000173 | 40.69 | gold quality |
| jejunal mucosa | UBERON:0000399 | 40.59 | gold quality |
| biceps brachii | UBERON:0001507 | 40.57 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 40.45 | gold quality |
| myocardium | UBERON:0002349 | 40.45 | gold quality |
| gingival epithelium | UBERON:0001949 | 40.43 | gold quality |
| granulocyte | CL:0000094 | 40.35 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 40.33 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 40.29 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 40.27 | gold quality |
| jejunum | UBERON:0002115 | 40.18 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.98 |
Regulation
Is transcription factor: no
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tas2r200.2 | ENSDARG00000074066 |
| danio_rerio | tas2r200.1 | ENSDARG00000079880 |
| mus_musculus | Tas2r144 | ENSMUSG00000051917 |
| rattus_norvegicus | Tas2r144 | ENSRNOG00000028130 |
Paralogs (23): TAS2R8 (ENSG00000121314), TAS2R10 (ENSG00000121318), TAS2R7 (ENSG00000121377), TAS2R9 (ENSG00000121381), TAS2R3 (ENSG00000127362), TAS2R4 (ENSG00000127364), TAS2R5 (ENSG00000127366), TAS2R16 (ENSG00000128519), TAS2R1 (ENSG00000169777), TAS2R60 (ENSG00000185899), TAS2R42 (ENSG00000186136), TAS2R19 (ENSG00000212124), TAS2R50 (ENSG00000212126), TAS2R14 (ENSG00000212127), TAS2R13 (ENSG00000212128), TAS2R41 (ENSG00000221855), TAS2R46 (ENSG00000226761), TAS2R39 (ENSG00000236398), TAS2R43 (ENSG00000255374), TAS2R20 (ENSG00000255837), TAS2R30 (ENSG00000256188), TAS2R31 (ENSG00000256436), TAS2R38 (ENSG00000257138)
Protein
Protein identifiers
Taste receptor type 2 member 40 — P59535 (reviewed: P59535)
Alternative names: G-protein coupled receptor 60, Taste receptor type 2 member 58
All UniProt accessions (1): P59535
UniProt curated annotations — full annotation on UniProt →
Function. Gustducin-coupled receptor implicated in the perception of bitter compounds in the oral cavity and the gastrointestinal tract. Signals through PLCB2 and the calcium-regulated cation channel TRPM5.
Subcellular location. Membrane.
Tissue specificity. Expressed in subsets of taste receptor cells of the tongue and exclusively in gustducin-positive cells.
Miscellaneous. Several bitter taste receptors are expressed in a single taste receptor cell.
Similarity. Belongs to the G-protein coupled receptor T2R family.
RefSeq proteins (1): NP_795363* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007960 | TAS2R | Family |
Pfam: PF05296
UniProt features (20 total): topological domain 8, transmembrane region 7, glycosylation site 2, sequence variant 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P59535-F1 | 81.19 | 0.36 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (2): 170, 179
Function
Pathways and Gene Ontology
Reactome pathways
9 pathways
| ID | Pathway |
|---|---|
| R-HSA-418594 | G alpha (i) signalling events |
| R-HSA-420499 | Class C/3 (Metabotropic glutamate/pheromone receptors) |
| R-HSA-9717207 | Sensory perception of sweet, bitter, and umami (glutamate) taste |
| R-HSA-162582 | Signal Transduction |
| R-HSA-372790 | Signaling by GPCR |
| R-HSA-388396 | GPCR downstream signalling |
| R-HSA-500792 | GPCR ligand binding |
| R-HSA-9709957 | Sensory Perception |
| R-HSA-9717189 | Sensory perception of taste |
MSigDB gene sets: 41 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, GOBP_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_TASTE, GOBP_SENSORY_PERCEPTION_OF_TASTE, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, OCT1_B, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_BITTER_TASTE_RECEPTOR_ACTIVITY, GOMF_TASTE_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, MIKKELSEN_MCV6_LCP_WITH_H3K27ME3, OCT_Q6, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, GOBP_SENSORY_PERCEPTION_OF_BITTER_TASTE
GO Biological Process (4): detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of taste (GO:0050909)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), bitter taste receptor activity (GO:0033038)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-6 pathways:
| Category | Pathways |
|---|---|
| Signaling by GPCR | 2 |
| GPCR downstream signalling | 1 |
| GPCR ligand binding | 1 |
| Sensory perception of taste | 1 |
| Signal Transduction | 1 |
| Sensory Perception | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| detection of chemical stimulus involved in sensory perception of taste | 1 |
| sensory perception of bitter taste | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| transmembrane signaling receptor activity | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of bitter taste | 1 |
| taste receptor activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
236 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TAS2R40 | SCNN1B | P51168 | 337 |
| TAS2R40 | TAS1R2 | Q8TE23 | 333 |
| TAS2R40 | PLCB2 | Q00722 | 255 |
| TAS2R40 | ZNF615 | Q8N8J6 | 251 |
| TAS2R40 | TAS2R50 | P59544 | 250 |
| TAS2R40 | TAS2R30 | P59541 | 242 |
| TAS2R40 | ERI2 | A8K979 | 239 |
| TAS2R40 | TAS2R31 | P59538 | 234 |
| TAS2R40 | TAS2R43 | P59537 | 234 |
| TAS2R40 | TAS2R14 | Q9NYV8 | 232 |
| TAS2R40 | TAS2R20 | P59543 | 227 |
| TAS2R40 | TAS2R3 | Q9NYW6 | 224 |
| TAS2R40 | PKD1L3 | Q7Z443 | 224 |
| TAS2R40 | GNAT3 | A8MTJ3 | 222 |
| TAS2R40 | TAS2R38 | P59533 | 219 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: P04201, P12526, P23749, P30554, P35410, P59534, P59535, Q3KNA1, Q3UG50, Q3UG61, Q4VHE7, Q645S5, Q645U4, Q645Y7, Q645Y8, Q645Y9, Q646A9, Q646B0, Q646C8, Q646D3, Q646F0, Q646F1, Q67ER9, Q67ES7, Q67ET0, Q67ET2, Q7TN38, Q7TN41, Q7TN44, Q7TN51, Q7TQA5, Q7TQA6, Q7TQB8, Q8CIP3, Q8R4G1, Q8TDS7, Q8VCJ6, Q91WW2, Q91WW3, Q91ZB8
Diamond homologs: P59530, P59532, P59534, P59535, P59536, P59551, Q2AB83, Q50KZ9, Q645S5, Q645T0, Q645T3, Q645T4, Q645T7, Q645T9, Q645U2, Q645U4, Q645U5, Q645U6, Q645U8, Q645U9, Q645V0, Q645V1, Q645V8, Q645V9, Q645Y3, Q645Y7, Q645Y8, Q645Y9, Q645Z0, Q645Z2, Q645Z4, Q645Z5, Q645Z7, Q646A2, Q646A3, Q646A9, Q646B0, Q646B1, Q646B2, Q646B5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
43 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 39 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
256 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:143222887:T:G | acceptor_gain | 0.8500 |
| 7:143222901:A:AG | acceptor_gain | 0.8500 |
| 7:143222902:G:GG | acceptor_gain | 0.8500 |
| 7:143222677:T:TA | acceptor_gain | 0.8100 |
| 7:143222884:A:G | acceptor_gain | 0.8000 |
| 7:143222209:GGGC:G | donor_gain | 0.7900 |
| 7:143222877:AC:A | acceptor_gain | 0.7900 |
| 7:143222923:A:G | acceptor_gain | 0.7600 |
| 7:143222210:GGC:G | donor_gain | 0.7400 |
| 7:143222673:AACAT:A | acceptor_gain | 0.7300 |
| 7:143222878:C:CA | acceptor_gain | 0.7200 |
| 7:143222211:GC:G | donor_gain | 0.7100 |
| 7:143222902:GTTC:G | acceptor_gain | 0.7100 |
| 7:143222883:A:AG | acceptor_gain | 0.7000 |
| 7:143222902:GTTCC:G | acceptor_gain | 0.7000 |
| 7:143222878:C:G | acceptor_gain | 0.6900 |
| 7:143222885:C:G | acceptor_gain | 0.6900 |
| 7:143222886:A:AG | acceptor_gain | 0.6900 |
| 7:143222182:G:GT | donor_gain | 0.6800 |
| 7:143222678:G:A | acceptor_gain | 0.6800 |
| 7:143222902:GT:G | acceptor_gain | 0.6800 |
| 7:143222701:T:G | acceptor_gain | 0.6700 |
| 7:143222900:CAGTT:C | acceptor_loss | 0.6700 |
| 7:143222901:A:AC | acceptor_loss | 0.6700 |
| 7:143222902:G:GC | acceptor_loss | 0.6700 |
| 7:143222761:G:T | donor_gain | 0.6600 |
| 7:143222858:A:AG | acceptor_gain | 0.6600 |
| 7:143222896:C:G | acceptor_gain | 0.6600 |
| 7:143222147:G:GA | donor_gain | 0.6500 |
| 7:143222212:C:G | donor_gain | 0.6500 |
AlphaMissense
2146 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:143222703:T:C | F209L | 0.865 |
| 7:143222705:C:A | F209L | 0.865 |
| 7:143222705:C:G | F209L | 0.865 |
| 7:143222547:A:C | S157R | 0.859 |
| 7:143222549:C:A | S157R | 0.859 |
| 7:143222549:C:G | S157R | 0.859 |
| 7:143222268:A:C | S64R | 0.855 |
| 7:143222270:C:A | S64R | 0.855 |
| 7:143222270:C:G | S64R | 0.855 |
| 7:143222190:T:C | F38L | 0.837 |
| 7:143222192:C:A | F38L | 0.837 |
| 7:143222192:C:G | F38L | 0.837 |
| 7:143222184:A:C | S36R | 0.825 |
| 7:143222186:T:A | S36R | 0.825 |
| 7:143222186:T:G | S36R | 0.825 |
| 7:143222430:T:C | F118L | 0.815 |
| 7:143222432:C:A | F118L | 0.815 |
| 7:143222432:C:G | F118L | 0.815 |
| 7:143222385:T:C | F103L | 0.782 |
| 7:143222387:T:A | F103L | 0.782 |
| 7:143222387:T:G | F103L | 0.782 |
| 7:143222832:T:C | F252L | 0.776 |
| 7:143222834:T:A | F252L | 0.776 |
| 7:143222834:T:G | F252L | 0.776 |
| 7:143222406:T:A | W110R | 0.753 |
| 7:143222406:T:C | W110R | 0.753 |
| 7:143222826:A:C | S250R | 0.719 |
| 7:143222828:C:A | S250R | 0.719 |
| 7:143222828:C:G | S250R | 0.719 |
| 7:143222367:T:C | F97L | 0.708 |
dbSNP variants (sampled 300 via entrez): RS1000682814 (7:143221394 G>A), RS1000821727 (7:143221142 G>A), RS1001510229 (7:143223452 A>G,T), RS1002116890 (7:143220219 G>A), RS1003801078 (7:143221368 G>A), RS1004196094 (7:143221571 A>G), RS1005417690 (7:143220268 A>C), RS1005491313 (7:143220497 T>G), RS1006160007 (7:143220361 T>A,C), RS1006641243 (7:143220893 A>T), RS1006745027 (7:143220858 A>G), RS1007042096 (7:143221231 A>G), RS1008617834 (7:143222485 G>A), RS1011617924 (7:143223161 C>A,T), RS1012447527 (7:143221660 G>T)
Disease associations
OMIM: gene MIM:613964 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL4523250 (SINGLE PROTEIN)
Molecules with ChEMBL bioactivity
1 molecules (phase ≥1), by development phase (incl. off-target/promiscuous compounds). Patent mentions across the top 20 by phase: 40,234 (via chembl_molecule»patent_compound — counts attach to the compound, not the gene–compound relationship, so off-target/promiscuous molecules can dominate).
| Molecule | Name | Phase | Patents |
|---|---|---|---|
| CHEMBL434 | ISOPROTERENOL | 4 | 40,234 |
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: gpcr — Taste 2 receptors
Most potent curated ligand interactions (2 total), top 2:
| Ligand | Action | Affinity | Parameter |
|---|---|---|---|
| cohumulone | Agonist | 7.4 | pEC50 |
| GIV3727 | Antagonist | 5.2 | pIC50 |
ChEMBL bioactivities
1 potent at pChembl≥5 of 1 total, top 1 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 8.31 | EC50 | 4.9 | nM | ISOPROTERENOL |
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| arsenite | decreases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Asbestos, Crocidolite | affects expression | 1 |
| Zinc Sulfate | increases expression | 1 |
| Particulate Matter | decreases expression | 1 |
ChEMBL screening assays
6 unique, capped per target: 6 functional
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4419015 | Functional | Agonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R40 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assay | Methods of identifying antagonists of the hTAS2R46 bitter taste receptor |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.